Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. Academic Article uri icon

Overview

MeSH Major

  • Angina Pectoris
  • Enoxaparin
  • Fibrinolytic Agents
  • Heparin

abstract

  • Enoxaparin was not superior to unfractionated heparin but was noninferior for the treatment of high-risk patients with non-ST-segment elevation ACS. Enoxaparin is a safe and effective alternative to unfractionated heparin and the advantages of convenience should be balanced with the modest excess of major bleeding.

authors

publication date

  • January 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 15238590

Additional Document Info

start page

  • 45

end page

  • 54

volume

  • 292

number

  • 1